nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromhexine—Abdominal pain upper—Didanosine—acquired immunodeficiency syndrome	0.018	0.018	CcSEcCtD
Bromhexine—Abdominal pain upper—Nelfinavir—acquired immunodeficiency syndrome	0.0157	0.0157	CcSEcCtD
Bromhexine—Abdominal pain upper—Abacavir—acquired immunodeficiency syndrome	0.0154	0.0154	CcSEcCtD
Bromhexine—Bronchospasm—Nelfinavir—acquired immunodeficiency syndrome	0.0146	0.0146	CcSEcCtD
Bromhexine—Angioedema—Amprenavir—acquired immunodeficiency syndrome	0.0119	0.0119	CcSEcCtD
Bromhexine—Immune system disorder—Nevirapine—acquired immunodeficiency syndrome	0.0111	0.0111	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Amprenavir—acquired immunodeficiency syndrome	0.011	0.011	CcSEcCtD
Bromhexine—Immune system disorder—Nelfinavir—acquired immunodeficiency syndrome	0.0107	0.0107	CcSEcCtD
Bromhexine—Immune system disorder—Abacavir—acquired immunodeficiency syndrome	0.0105	0.0105	CcSEcCtD
Bromhexine—Skin disorder—Amprenavir—acquired immunodeficiency syndrome	0.0103	0.0103	CcSEcCtD
Bromhexine—Abdominal pain upper—Saquinavir—acquired immunodeficiency syndrome	0.0102	0.0102	CcSEcCtD
Bromhexine—Angioedema—Nevirapine—acquired immunodeficiency syndrome	0.00977	0.00977	CcSEcCtD
Bromhexine—Abdominal pain upper—Lamivudine—acquired immunodeficiency syndrome	0.00971	0.00971	CcSEcCtD
Bromhexine—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.0097	0.0097	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.00919	0.00919	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Nevirapine—acquired immunodeficiency syndrome	0.00904	0.00904	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Nelfinavir—acquired immunodeficiency syndrome	0.00875	0.00875	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Stavudine—acquired immunodeficiency syndrome	0.00872	0.00872	CcSEcCtD
Bromhexine—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.00872	0.00872	CcSEcCtD
Bromhexine—Immune system disorder—Indinavir—acquired immunodeficiency syndrome	0.00865	0.00865	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.00859	0.00859	CcSEcCtD
Bromhexine—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.00847	0.00847	CcSEcCtD
Bromhexine—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.0083	0.0083	CcSEcCtD
Bromhexine—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.0082	0.0082	CcSEcCtD
Bromhexine—Angioedema—Zidovudine—acquired immunodeficiency syndrome	0.00819	0.00819	CcSEcCtD
Bromhexine—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.00818	0.00818	CcSEcCtD
Bromhexine—Immune system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00818	0.00818	CcSEcCtD
Bromhexine—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.00806	0.00806	CcSEcCtD
Bromhexine—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.00762	0.00762	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.00758	0.00758	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.00753	0.00753	CcSEcCtD
Bromhexine—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00753	0.00753	CcSEcCtD
Bromhexine—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00732	0.00732	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00729	0.00729	CcSEcCtD
Bromhexine—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.00728	0.00728	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.00727	0.00727	CcSEcCtD
Bromhexine—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00723	0.00723	CcSEcCtD
Bromhexine—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.0072	0.0072	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00716	0.00716	CcSEcCtD
Bromhexine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00715	0.00715	CcSEcCtD
Bromhexine—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.00711	0.00711	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.00705	0.00705	CcSEcCtD
Bromhexine—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00696	0.00696	CcSEcCtD
Bromhexine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00693	0.00693	CcSEcCtD
Bromhexine—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.00689	0.00689	CcSEcCtD
Bromhexine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00686	0.00686	CcSEcCtD
Bromhexine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00681	0.00681	CcSEcCtD
Bromhexine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00677	0.00677	CcSEcCtD
Bromhexine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00671	0.00671	CcSEcCtD
Bromhexine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00671	0.00671	CcSEcCtD
Bromhexine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.0067	0.0067	CcSEcCtD
Bromhexine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00669	0.00669	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.00666	0.00666	CcSEcCtD
Bromhexine—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00664	0.00664	CcSEcCtD
Bromhexine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00664	0.00664	CcSEcCtD
Bromhexine—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.00661	0.00661	CcSEcCtD
Bromhexine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00659	0.00659	CcSEcCtD
Bromhexine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00643	0.00643	CcSEcCtD
Bromhexine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00632	0.00632	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00632	0.00632	CcSEcCtD
Bromhexine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00625	0.00625	CcSEcCtD
Bromhexine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00622	0.00622	CcSEcCtD
Bromhexine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.0062	0.0062	CcSEcCtD
Bromhexine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00617	0.00617	CcSEcCtD
Bromhexine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00617	0.00617	CcSEcCtD
Bromhexine—Rash—Didanosine—acquired immunodeficiency syndrome	0.00612	0.00612	CcSEcCtD
Bromhexine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00611	0.00611	CcSEcCtD
Bromhexine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00611	0.00611	CcSEcCtD
Bromhexine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00598	0.00598	CcSEcCtD
Bromhexine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00598	0.00598	CcSEcCtD
Bromhexine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00597	0.00597	CcSEcCtD
Bromhexine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00596	0.00596	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.0059	0.0059	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00588	0.00588	CcSEcCtD
Bromhexine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00587	0.00587	CcSEcCtD
Bromhexine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.00585	0.00585	CcSEcCtD
Bromhexine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00581	0.00581	CcSEcCtD
Bromhexine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00578	0.00578	CcSEcCtD
Bromhexine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00576	0.00576	CcSEcCtD
Bromhexine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00576	0.00576	CcSEcCtD
Bromhexine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00568	0.00568	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.00567	0.00567	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00555	0.00555	CcSEcCtD
Bromhexine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00555	0.00555	CcSEcCtD
Bromhexine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00553	0.00553	CcSEcCtD
Bromhexine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.0055	0.0055	CcSEcCtD
Bromhexine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00549	0.00549	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00541	0.00541	CcSEcCtD
Bromhexine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00541	0.00541	CcSEcCtD
Bromhexine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00537	0.00537	CcSEcCtD
Bromhexine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00535	0.00535	CcSEcCtD
Bromhexine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00533	0.00533	CcSEcCtD
Bromhexine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00532	0.00532	CcSEcCtD
Bromhexine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00532	0.00532	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00531	0.00531	CcSEcCtD
Bromhexine—Rash—Stavudine—acquired immunodeficiency syndrome	0.00531	0.00531	CcSEcCtD
Bromhexine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.0053	0.0053	CcSEcCtD
Bromhexine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00527	0.00527	CcSEcCtD
Bromhexine—Rash—Abacavir—acquired immunodeficiency syndrome	0.00523	0.00523	CcSEcCtD
Bromhexine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00523	0.00523	CcSEcCtD
Bromhexine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00523	0.00523	CcSEcCtD
Bromhexine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00518	0.00518	CcSEcCtD
Bromhexine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00518	0.00518	CcSEcCtD
Bromhexine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00511	0.00511	CcSEcCtD
Bromhexine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00508	0.00508	CcSEcCtD
Bromhexine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00502	0.00502	CcSEcCtD
Bromhexine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00502	0.00502	CcSEcCtD
Bromhexine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00501	0.00501	CcSEcCtD
Bromhexine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.005	0.005	CcSEcCtD
Bromhexine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00493	0.00493	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00491	0.00491	CcSEcCtD
Bromhexine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00489	0.00489	CcSEcCtD
Bromhexine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00482	0.00482	CcSEcCtD
Bromhexine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00474	0.00474	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00473	0.00473	CcSEcCtD
Bromhexine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00466	0.00466	CcSEcCtD
Bromhexine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00465	0.00465	CcSEcCtD
Bromhexine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00462	0.00462	CcSEcCtD
Bromhexine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00461	0.00461	CcSEcCtD
Bromhexine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00455	0.00455	CcSEcCtD
Bromhexine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00453	0.00453	CcSEcCtD
Bromhexine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00452	0.00452	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00451	0.00451	CcSEcCtD
Bromhexine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.0044	0.0044	CcSEcCtD
Bromhexine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00435	0.00435	CcSEcCtD
Bromhexine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00435	0.00435	CcSEcCtD
Bromhexine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00435	0.00435	CcSEcCtD
Bromhexine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00433	0.00433	CcSEcCtD
Bromhexine—Rash—Indinavir—acquired immunodeficiency syndrome	0.00429	0.00429	CcSEcCtD
Bromhexine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00429	0.00429	CcSEcCtD
Bromhexine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00421	0.00421	CcSEcCtD
Bromhexine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00419	0.00419	CcSEcCtD
Bromhexine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00415	0.00415	CcSEcCtD
Bromhexine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00409	0.00409	CcSEcCtD
Bromhexine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00406	0.00406	CcSEcCtD
Bromhexine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00405	0.00405	CcSEcCtD
Bromhexine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00404	0.00404	CcSEcCtD
Bromhexine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00404	0.00404	CcSEcCtD
Bromhexine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00403	0.00403	CcSEcCtD
Bromhexine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00391	0.00391	CcSEcCtD
Bromhexine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00389	0.00389	CcSEcCtD
Bromhexine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00388	0.00388	CcSEcCtD
Bromhexine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00388	0.00388	CcSEcCtD
Bromhexine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00388	0.00388	CcSEcCtD
Bromhexine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00385	0.00385	CcSEcCtD
Bromhexine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00382	0.00382	CcSEcCtD
Bromhexine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00375	0.00375	CcSEcCtD
Bromhexine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.0037	0.0037	CcSEcCtD
Bromhexine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00366	0.00366	CcSEcCtD
Bromhexine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00362	0.00362	CcSEcCtD
Bromhexine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00359	0.00359	CcSEcCtD
Bromhexine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00358	0.00358	CcSEcCtD
Bromhexine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00358	0.00358	CcSEcCtD
Bromhexine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00348	0.00348	CcSEcCtD
Bromhexine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00345	0.00345	CcSEcCtD
Bromhexine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00345	0.00345	CcSEcCtD
Bromhexine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00338	0.00338	CcSEcCtD
Bromhexine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00332	0.00332	CcSEcCtD
Bromhexine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00329	0.00329	CcSEcCtD
Bromhexine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00329	0.00329	CcSEcCtD
Bromhexine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00325	0.00325	CcSEcCtD
Bromhexine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.0031	0.0031	CcSEcCtD
